Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.

Kabra Drugs informs about standalone financial results

15 Feb 2017

Kabra Drugs has informed about Standalone Financial Results, Limited Review for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Related Kabra Drugs Ltd. Links:

Kabra Drugs Share Price

5.61 0.00 (0.00%) Nov 22, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 751.80
Cipla 911.85
Dr. Reddy's Lab 4607.25
Aurobindo Pharma 674.35
Lupin 873.10
View more..
Sensex vs Kabra Drugs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback